Open Access

The Use of Inhaled Epoprostenol for Acute Respiratory Distress Syndrome Secondary due to COVID-19: A Case Series

Komal Imtiaz

Komal Imtiaz

University of Texas at HoustonHouston, USA
Search for this author on
Sciendo|Google Scholar
Imtiaz, Komal
, 
Wade Jodeh

Wade Jodeh

St Joseph Mercy Ann ArborAnn Arbor, USA
Search for this author on
Sciendo|Google Scholar
Jodeh, Wade
, 
Dave Sudekum

Dave Sudekum

St Joseph Mercy Ann ArborAnn Arbor, USA
Search for this author on
Sciendo|Google Scholar
Sudekum, Dave
, 
Bruno DiGiovine

Bruno DiGiovine

St Joseph Mercy Ann ArborAnn Arbor, USA
Search for this author on
Sciendo|Google Scholar
DiGiovine, Bruno
 and 
Jason Hecht

Jason Hecht

St Joseph Mercy Ann ArborAnn Arbor, USA
Search for this author on
Sciendo|Google Scholar
Hecht, Jason
  
Nov 17, 2021
The Use of Inhaled Epoprostenol for Acute Respiratory Distress Syndrome Secondary due to COVID-19: A Case Series's Cover Image
About this article
Previous Article
Next Article
Cite
Download Cover
Article Category: Case report
Published Online: Nov 17, 2021
Page range: 33 - 40
Received: Nov 24, 2020
Accepted: Sep 27, 2021
DOI: https://doi.org/10.2478/jccm-2021-0037
Keywords
© 2022 Komal Imtiaz, Wade Jodeh, Dave Sudekum, Bruno DiGiovine, Jason Hecht, published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Clinical Medicine, Internal Medicine, Internal Medicine, other, Surgery, Surgery, other, Anaesthesiology, Emergency Medicine and Intensive-Care Medicine
Journal RSS Feed